The new Ahpra and National Boards guidelines for higher-risk non-surgical cosmetic procedures now apply, and the TGA polices how injectables are referred to at all.
Perfect results, every time.
Sydney’s home of anti-wrinkle injections
Sample output. Fictional practice. Not legal advice.
Ahpra and the TGA each have their own rules for cosmetic clinic advertising, and they overlap. SwayBlu applies both to your website and shows you every phrase that creates risk.
Ahpra and the National Boards published dedicated guidelines for higher-risk non-surgical cosmetic procedures, in force from 2 September 2025. Five categories cover what clinic advertising must and must not do.
Advertising higher-risk procedures must include the practitioner's registration information. "Specialist" requires a matching specialist registration on the national register, and there is no cosmetic or aesthetic specialty recognised under Australian law.
Outcome imagery requires a warning that results vary between patients, plus risk and recovery information presented alongside it. A before-and-after photo without that context is non-compliant on its face.
Testimonials are prohibited. Reposting a patient's own social media content counts as a testimonial under the guidelines. Influencer advertising must meet the same standard as any other form of promotion for higher-risk procedures.
Advertising must not idealise or sexualise content, exploit body image concerns, or minimise risk. Phrases like "no downtime" or "pain free" without balanced information about what recovery actually involves are non-compliant.
Advertising higher-risk cosmetic procedures to minors is banned. Social accounts promoting these procedures should be age-restricted to 18 and over.
The Therapeutic Goods Administration has its own rules for prescription medicines, independent of the Ahpra guidelines, and they apply to injectables in full.
Naming products or ingredients such as Botox and botulinum toxin in consumer-facing advertising was never permitted under the Therapeutic Goods Act 1989.
Since 7 March 2024, class terms such as "wrinkle reducing injections" or "dermal fillers" are no longer permitted where a reasonable consumer would understand a prescription medicine is being promoted.
All of these are non-compliant forms of advertising for prescription medicines. This applies whether the product is named by its brand, its generic name, or a class term.
The same engine that flags the breaches writes the alternative: on-brand, checked against both rulebooks before you ever see it.
Sample content for a fictional clinic, generated by SwayBlu’s image engine.
Maximum penalty per advertising breach under the Health Practitioner Regulation National Law.
Up to $18.2 million at the $364 penalty unit value current from 1 July 2026.
3.16 likely breaches per site on average. Sites we audited, not a national estimate.
Paste your URL and SwayBlu checks your clinic site against the Ahpra guidelines and the TGA rules in the same pass. Every flagged phrase comes back with the rule it risks and a suggested rewrite. Then the product writes weekly content that passes the same checks before you see it.
Free. No card. Not legal advice.
Free audit. No card. SwayBlu reads your clinic site the way Ahpra and the TGA read it.
No card needed.
SwayBlu is a content tool, not a legal advice service. Its checks flag likely issues against the Ahpra/National Boards Guidelines for advertising higher risk non-surgical cosmetic procedures (in effect 2 September 2025) and TGA advertising rules for prescription medicines. They are not legal advice and are not a substitute for advice from a qualified practitioner. You are the publisher of record and final compliance of any content you publish is your responsibility. SwayBlu is not affiliated with, endorsed by, or acting for Ahpra, the National Boards or the Therapeutic Goods Administration.
The sample audit output on this page is illustrative work for a fictional clinic. "Radiant Skin Studio" is a fictional name and does not refer to any real business.